HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients.

Abstract
Because fibrosis progression resulting in liver cirrhosis represents the main reason for graft lost in patients after liver transplantation, an early detection of liver fibrosis is crucial. In recent years, several non-invasive tests for the assessment of liver fibrosis have been developed. We prospectively assessed the stage of liver fibrosis of 135 liver transplant patients (94 hepatitis C virus [HCV], 41 alcoholic cirrhosis) using liver biopsy, transient elastography, and serum markers. In the HCV group, the area under the receiver operating characteristic curve (AUROC) for diagnosis of significant fibrosis (F ≥ 2) and cirrhosis (F = 4) was 0.81 (negative predictive value [NPV] = 0.58, positive predictive value [PPV] = 0.9) and 0.87 (NPV = 0.94, PPV = 0.56), respectively. In the alcoholic cirrhosis group, significant fibrosis (F ≥ 2) was diagnosed with an AUROC of 0.83 (NPV = 1.00, PPV = 0.23). In both groups, higher AUROC values were reached in patients with a body mass index of <25 kg/m(2) , and both serum markers showed no significant correlation to liver fibrosis. The transient elastography is a reliable test for exclusion of liver cirrhosis in HCV transplant and significant liver fibrosis in alcoholic transplant patients. For the diagnosis of significant liver fibrosis in HCV transplant patients, the transient elastography reaches good results but cannot replace liver biopsy. Both serum markers AST-to-platelet ratio index and FIB-4 are not feasible to assess liver fibrosis in liver transplant patients.
AuthorsCarsten Kamphues, Katharina Lotz, Christoph Röcken, Thomas Berg, Dennis Eurich, Johann Pratschke, Peter Neuhaus, Ulf P Neumann
JournalClinical transplantation (Clin Transplant) 2010 Sep-Oct Vol. 24 Issue 5 Pg. 652-9 ISSN: 1399-0012 [Electronic] Denmark
PMID19925459 (Publication Type: Journal Article)
Copyright© 2009 John Wiley & Sons A/S.
Chemical References
  • Biomarkers
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Elasticity Imaging Techniques
  • Female
  • Graft Survival
  • Hepatitis C (complications, surgery)
  • Humans
  • Liver Cirrhosis (blood, diagnosis, etiology)
  • Liver Cirrhosis, Alcoholic (complications, surgery)
  • Liver Transplantation
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prospective Studies
  • Risk Factors
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: